BioIQ Conducts One Millionth Colorectal Cancer Screening

BioIQ a healthcare engagement and gap closure company that is redefining the way payers, employers and consumers navigate and connect with the U.S. healthcare system, announced today that it has conducted its one millionth colorectal cancer screening. BioIQ reached this key milestone, often helping unengaged or disadvantaged populations, in a short timeframe not simply with an at-home test kit, but by facilitating care using consumer analytics, omni-channel engagement, and a curated network of partner solutions. This combination of capabilities in a single technology platform is being leveraged to produce a similar impact across a myriad of other major health conditions.